SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000905718-20-000776
Filing Date
2020-07-27
Accepted
2020-07-24 17:42:28
Documents
2
Group Members
LEDO CAPITAL, LLCNEWTYN CAPITAL PARTNERS, LPNEWTYN PARTNERS, LPNOAH G. LEVY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A merrimack_13dam2jul222020.htm SC 13D/A 83529
2 EX-99.1 merrimack_13dam2jul222020ex.htm EX-99 13297
  Complete submission text file 0000905718-20-000776.txt   98483
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86778 | Film No.: 201047723
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A